ReviewExperimental & molecular medicine2024

PLD1 is a key player in cancer stemness and chemoresistance: Therapeutic targeting of cross-talk between the PI3K/Akt and Wnt/β-catenin pathways.

Seong Hun Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.